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Abstract
Background: Fanconi anemia (FA) is a chromosomal instability syndrome characterized by increased frequency of
chromosomal breakages, chromosomal radial figures and accelerated telomere shortening. In this work we
performed detailed molecular-cytogenetic characterization of breakpoints in primary lymphocytes of FA-D2 patients
in different stages of the disease using fluorescent in situ hybridization.
Results: We found that chromosomal breakpoints co-localize on the molecular level with common fragile sites,
whereas their distribution pattern depends on the severity of the disease. Telomere quantitative fluorescent in situ
hybridization revealed that telomere fusions and radial figures, especially radials which involve telomere sequences
are the consequence of critically shortened telomeres that increase with the disease progression and could be
considered as a predictive parameter during the course of the disease. Sex chromosomes in FA cells are also
involved in radial formation indicating that specific X chromosome regions share homology with autosomes and
also could serve as repair templates in resolving DNA damage.
Conclusions: FA-D2 chromosomal breakpoints co-localize with common fragile sites, but their distribution pattern
depends on the disease stage. Telomere fusions and radials figures which involve telomere sequences are the
consequence of shortened telomeres, increase with disease progression and could be of predictive value.
Keywords: Fanconi anemia, Fragile sites, Telomere fusions, Radial figures, X chromosome
Background
Fanconi anemia (FA) is a rare, inherited, genetically het-
erogeneous chromosomal instability syndrome. To date,
19 different complementation groups, which correspond
to distinct DNA repair genes have been identified, FA-A,
FA-B, FA-C, FA-D1 (BRCA2), FA-D2, FA-E, FA-F, FA-G,
FA-I, FA-J (BRIP1), FA-M, FA-N (PALB2), FA-O
(RAD51C), FA-P (SLX4), FA-Q (ERCC4), FA-S (BRCA1),
FA-R (RAD51) and FA-T (UBE2T) [1]. The genes that
correspond to different FA complementation groups are in-
volved in the FA/BRCA DNA damage repair pathway hav-
ing an essential function in the cellular response to stress
induced by DNA alkylating agents [2]. The most frequent
complementation group in Serbia is FA-D2 [3], which is in
contrast to the FA-D2 frequency in the general population
where it accounts for approximately 4 % of all complemen-
tation groups [4]. FA-D2 patients are characterized by a
broad spectrum of congenital abnormalities and, unlike
most of the other FA complementation groups, an early on-
set of hematological manifestations including acute myelog-
enous leukemia and bone marrow failure [5]. One of the
most significant FA cellular characteristics is an increase of
chromosomal aberrations induced by interstrand cross-
linking (ICL) agents [6]. When exposed to these agents, FA
cells show an increased frequency of chromosomal break-
ages and chromosomal radial figures, prolonged cell-cycle
arrest in G2/M phase, reduced cellular survival and acceler-
ated telomere shortening [7]. With respect to chromosomal
* Correspondence: gjoksic@vinca.rs
1Vinca Institute of Nuclear Sciences, University of Belgrade, Mike Petrovica
Alasa 12-14, Belgrade 11001, Serbia
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Filipović et al. Molecular Cytogenetics  (2016) 9:70 
DOI 10.1186/s13039-016-0280-6
breakages, Schoder and coworkers [8] reported that
chromosomal breakpoints in cells derived from FA-A and
FA-C patients co-localize with the chromosomal regions
that are constitutionally prone to breakage in each individ-
ual, known as common fragile sites (CFSs). In addition to
standard FS classification, it was shown that cells exposed
to replication stress also display breakages in telomeric re-
gions; therefore they were attributed to CFSs [9]. Recent
studies of telomere maintenance in FA cells showed that
telomere fusions arise either as a consequence of their crit-
ical shortening or altered capping function. High percent-
age of dysfunctional telomeres and marked telomere
fragility was found to be typical for FA-D2 cellular pheno-
type [10]. However, the role of telomeres in formation of in-
duced chromosomal aberrations such as radial figures has
not been determined, yet.
The aim of this study was to provide the first molecular-
cytogenetic characterization of breakpoint distribution
and co-localization with FSs, formation of radial figures
and involvement of telomeres in formation of chromo-
somal aberrations in FA-D2 primary lymphocytes origi-
nated from patients in different stages of the disease,
severe and mild bone marrow failure stage.
Methods
Patients and sampling
A total of six patients (five females, one male) previously
diagnosed with FA-D2 [3, 10] were included in our
study. Mean age of children at the time of study was 8 ±
5 years. Routine control of those children was under-
taken at the Mother and Child Health Care Institute of
Serbia, Hematooncology department. Disease stage was
determined based on complete blood count (CBC) and
bone marrow examination using standard criteria. Chil-
dren were divided into two groups accordingly: severe
(group A) or mild (group B) bone marrow failure (BMF).
Informed consents from the families were obtained and
peripheral blood was collected in Li-heparin vaccutai-
ners for additional testing. The study was approved by
The Ethical Committee of Mother and Child Health
Care Institute of Serbia.
Whole blood cultures
Aliquots of heparinized whole blood (0.5 ml) were set
up in cultures containing PBmax-karyotyping medium
(Invitrogen-Gibco, Paisley, UK) and treated with diepox-
ibuthan (DEB, Sigma Chemicals Co., Germany) (final
concentration 0.1 μg/ml) 48 h after culture initiation
and further harvested 72 h after initiation. Colchicine
(Sigma-Aldrich, Munich, Germany) was added during
the last 3 h (final concentration 2.5 μg/ml). Cells were
collected by centrifugation and treated with hypotonic
solution (0.56 % KCl). Cell suspensions were fixed in
methanol/acetic acid (3:1), washed three times with fixa-
tive and dropped onto clean slides.
DAPI banding
Slides were incubated overnight at room temperature,
dehydrated in series of ethanol (70, 95 and 100 %,
respectively), 5 min each, and counterstained with 4′,6′-
diamidino-2-phenylindole (DAPI)-containing Vectashield
solution (Vector Laboratories Ltd, Peterborough, UK).
DAPI selectively binds to heterochromatin regions, which
produces a banding pattern known as inverse DAPI band-
ing. According to the unique pattern of differentially
stained regions each chromosome can be identified.
Analysis was performed with a Zeiss-Axioimager A1
microscope and the ISIS imaging software package
(MetaSystems, Altlussheim, Germany).
Locus-specific fluorescent in situ hybridization (Locus-
specific FISH, BAC-FISH)
After determination of the most frequent chromosomal
breakpoints by inverse DAPI staining, molecular
characterization was performed by hybridization with
appropriate bacterial artificial chromosome probes
(BAC-probes) as described by Mrasek et al. [11]. In
short, after removing DAPI, slides were incubated in
pepsin solution for 5 min, washed in 1xPBS and fixed
in 1 % formalin buffer solution. Prior to applying the
BAC-probe, slides were dehydrated in series of etha-
nol (70, 90, 100 %, 5 min each), denatured in 70 %
formamide solution for 2–3 min on a hot plate at 75 °C
and immediately placed in 70 % ethanol (4 °C) to conserve
target DNA single-stranded. Dehydration in 90 and 100 %
ethanol followed. The probe mixture (the probe in
hybridization buffer and COT1 Human DNA) was dena-
tured in a thermocycler at 75 °C for 5 min, pre-annealed
at 37 °C for 30 min and cooled down to 4 °C. Prepared de-
natured probes were applied to the slides and hybridized
overnight in a dark humid chamber at 37 °C. After
hybridization, the slides were washed in 4xSSC/0.2 %
Tween20 at the room temperature and 1xSSC-solution
(62–65 °C), dehydrated in series of ethanol, counterstained
with DAPI solution and observed under the fluorescence
microscope. The results were analyzed using ISIS software
(MetaSystems, Germany). The chromosomal regions and
associated BAC-probes used for hybridization are shown
in Table 1.
Telomere quantitative fluorescent in situ hybridization
(Q-FISH)
After metaphase analysis DAPI was removed, slides
hybridized with telomere cPNA oligonucleotide probe
(TTAGGG) as described by Slijepcevic [12]. Briefly,
hybridization was performed with the Cy-3 labeled telo-
meric PNA probe (CCCTAA) 3′ supplemented with PNA
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centromeric probe for chromosome 2 (DAKO,
Glostrup, Denmark) in final concentration 2 ng/ml.
The PNA probe for centromere 2 was added in ready
to use telomere probe. After hybridization slides were
left in a dark humidified chamber for 2 h. The slides
were then washed in 70 % formamide and stained
with 4′,6′-diamidino-2-phenylindole (DAPI)-contain-
ing mounting medium (Vector Laboratories, UK).
Analysis was performed using the ISIS software,
MetaSystems (Altlussheim, Germany). Measurements
were reported as arbitrary relative telomere length
units (RTLU), which are defined as the ratio of signal
intensity between telomeres and a centromere
chromosome 2 reference signals.
Metaphase analysis
Metaphase spreads were analyzed according to the
International System for Human Cytogenetic No-
menclature (ISCN, 2013). For each sample at least
1000 metaphases were analyzed for the breakpoint
characterization, whereas at least 500 metaphases
were scored for fusions and radial formation with re-
gard to the chromosomes involved in their formation,
and involvement of telomeres in arising of those
aberrations.
Statistical analysis
FA breakpoints were expressed as the percentage of total
number of breaks per patient. Telomere fusions and radial
figures were presented as percentage of total number of
metaphases analyzed and were statistically analyzed using
nonparametric Mann-Whitney U test in the program
SPSS 10 for Windows. Differences at p < 0.05 were consid-
ered as significant.
Results
FA breakpoints and assignment to FSs
Results of molecular cytogenetic characterization con-
cerning chromosomal breakages, telomere fusions and
radial figures in DEB treated peripheral blood derived
from three FA-D2 patients in the severe stage of diseases
(group A), and three patients in the mild stage of the
disease (group B) are presented in Table 2.
The FA breakpoint analysis showed that frequency of
breakages, and breakpoint distribution pattern depend
on the stage of the disease: most of the breakpoints in
both groups of patients corresponded to CFSs, except
for patient 1 in group A where one of the most frequent
breaks was 1q42.2 (Fig. 1). In the group A patients,
breakpoints were dispersed throughout the genome with
a much lower frequency of breakage at the particular
Table 1 BAC-probes used for fluorescence in situ hybridization for the most breakpoint-affected chromosomal regions
Chromosomal region Fragile site (FS) FS typea BAC-probe Co-localization of
FA breakpoints and FS
1p13.3 FRA1N Aphidicolinb RP11-242D10 +
1q21.2 FRA1F Aphidicolin RP11-301 M17 +
1q42.2 Near FRA1H Azacytidin RP11-109G24 −
2q35 FRA2U Aphidicolin RP11-316O14 +
3p14.2 FRA3B Aphidicolin RP11-129 K20 +
3p21.31 FRA3H New nomenclaturec RP11-787O14
RP11-159A17
+
3q27.1 FRA3C Aphidicolin RP11-110C15 +
5q13.2 FRA5K New nomenclatured RP11-497H16 +
5q33.2 FRA5O New nomenclatured RP11-265I24
RP11-494C5
+
7q22.3 FRA7F Aphidicolin CTB-20D2 +
7q32.3 FRA7H Aphidicolin RP11-138A9
RP11-36B6
+
11q13 FRA11H Aphidicolin RP11-449G14 +
14q24.3 FRA14G Aphidicolinb RP3-414A15 +
16q22.1 FRA16C, FRA16B Aphidicolin RP11-106 J23 +
16q23 FRA16D Aphidicolin RP11-358 L22 +
18q21.3 FRA18B Aphidicolin RP11-15C15 +
BAC-probes for the appropriate FSs were selected according to the literature data:
aNomenclature according to Lukusa et al. [33]
bNew extended nomenclature according to Mrasek et al. [34]
cCommon according to the nomenclature by Borgaonkar [35]
dCommon according to the nomenclature by Simonic and Gericke [36]
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Table 2 FA-D2 patients’ karyotypes and molecular cytogenetic findings
FA-D2
patient
Age
(years)
Karyotype Most
frequent
breakpoints
Fragile
site (FS)
Breakpoint
frequency
(%)
Telomere
fusion
frequency (%)
Average telomere
length (RTLUa ±
SD)
Radial figures
frequency
(%)
Group
A
1 8 46,XX 1q42.2 distal
to
FRA1H
1.72 1.95 14.76 ± 3.23 7.06
14q24.3 FRA14G 3.09
18q21.3 FRA18B 1.72
2 6 46,XX 2q35 FRA2U 2.4 1.54 23.02 ± 12.73 1.78
3p14.2 FRA3B 2.4
5q33.2 FRA5O 2
7q32.3 FRA7H 1.6
3 17 46,XX 3q27.1 FRA3C 2.75 1.62 35.72 ± 7.00 1.88
5q13.2 FRA5K 2.75
5q33.2 FRA5O 3.29
Group
B
4 3 46,XX 3p14.2 FRA3B 11.07 0.08 20.48 ± 12.24 0.78
3p21.31 FRA3H 3.95
7q32.3 FRA7H 1.19
5 3 46,XX,der(21)t(15;21)(q15;p11.1)[5]/
46,XX [15]
1p13 FRA1N 1.76 0.72 21.01 ± 10.33 0.715
1q21 FRA1F 1.32
3p21.31 FRA3H 1.32
11q13 FRA11H 0.88
6 11 46, XY,
der(16)t(1;16)(q42;p11.2)del(1)
(q42)[1]/46,XY[31]
3p14.2 FRA3B 1.88 0.23 23.91 ± 6.92 0.23
3p21.31 FRA3H 0.63
16q22.1 FRA16C 1.88
16q23 FRA16D 6.88
aRTLU–relative telomere length units
Fig. 1 Representative images of BAC-FISH in FA-D2 metaphases, inverted DAPI and DAPI staining. Arrows indicate breakpoints and hybridized
BAC-probes; RP11-265I24 located within FRA5O (a), and RP11-109G24 located within 1q42.2, near FRA1H (b)
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chromosomal locus, i.e. the most frequent breakpoints
within this group did not exceed 3.297 % of the total
number of breaks.
In contrast, chromosomes in patients of B group tended
to break with the higher frequency in the chromosomal
regions where the most CFSs are reported (Table 2). Inter-
individual variability in frequency of the most common
breakages was significant in this group, but the breakage
pattern in two patients from this group was similar: in pa-
tients 4 and 6 the highest frequency of breakage was ob-
served in regions that correspond to FRA3B (11.07 %) and
FRA16D (6.87 %), respectively. However, patient 5 had a
different breakage pattern compared to other two patients
within this group, where low frequencies of the common
breakages were found. However, this patient also shows an
unbalanced karyotype, mos 46,XX,der(21)t(15;21)(q15;p
11.1)[5]/46,XX[15].
Telomeres and radial figures
Frequency of telomere fusions and radial figures, with
special regard to their structure and telomere involve-
ment in radial figures formation, are presented in Table 2
and Figs. 2, 3 and 6.
The results showed significantly higher frequency of
telomere fusions in patients from group A versus group
B (p = 0.05, Fig. 2). Within A group of patients, telomere
fusions occurred most frequently between chromosomes
2p, 2q, 5q and 18q, whereas in group B fusions mostly
occurred between 6q, 7q, 9p, 10q, 18q (Fig. 4). Relative
quantification of telomere length revealed that the av-
erage telomere length (RTLU) was not significantly di-
fferent between two groups (p = 0.442). However,
quantification of telomere length at single chromosomes
showed that p/q ratio ranged from 0.41 to 2.18 and that
chromosomes with the shortest telomeres constituted
telomere end-to-end fusions.
The percentage of radial figures was low in group B
(below 1 %), whereas in group A the percentage was on
average six times higher than in group B (p = 0.05, Fig. 3).
Regarding radial figure structure, great percentage of ra-
dials found in group A was a consequence of exchange
between telomeres of one and non-telomeric, interstitial
regions of other chromosomes, 25.49 % (50 % of all ra-
dials in patient 1, and 22.7 % for patients 2 and 3, each).
Only two radials between telomeres and interstitial
chromosomal sequences were observed in patient 4 and
5, and neither one was observed in patient 6. Although
radials always arose between non-homologous chromo-
somes, distribution of involved chromosomes was het-
erogeneous–chromosomes 1, 2, 9, 10 and 14 were
frequently present in radial figures in group A patients,
and chromosome 1 was most frequent in group B.
Chromosome X was found to be involved in radial
figures in all group A patients and one group B patient
(Fig. 5). Representative images of telomere fusions,
radials and X chromosome in radial formation are pre-
sented in the Fig. 6.
Discussion
The results of our study revealed that chromosomes are
not equally prone to breakages in FA-D2 cells exposed
to DEB. Matching the data of DAPI banding and BAC-
FISH pointed out that regions with increased frequency
of breakages co-localize with the CFSs, indicating that
frequency of breakpoints as well as their distribution
pattern is different among patients and is related to the
disease stage.
Assignment of breakpoints to FS in FA-D2 cells is in
accordance to previously reported data for FA-A and
0.0%
1.0%
2.0%
3.0%
4.0%
Group A Group B
Telomere fusions (%)
Fig. 2 Percentage of telomere fusions in group A and B patients.
Group A display more fusions than group B
0.0%
1.0%
2.0%
3.0%
4.0%
Group A Group B
Radial figures (%)
Fig. 3 Percentage of radial figures in group A and B patients. In Group
A incidence of radials was six fold higher compared to group B
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FA-C cell lines, although the disease stage for the pa-
tients in this study was not determined [8]. In FA-D2 pa-
tients in the severe stage of the disease (group A) the
most frequent breakpoints were present within the CFSs
regions (FRA14G, FRA5O, FRA5K and FRA3C, Table 2)
except for patient 1 in group A where one of the most
frequent breaks was 1q42.2 which is near the FRA1H
[13]. However, previously it was not attributed as FS.
Their distribution pattern was similar to that found in
FA-A and FA-C patients, although different breakpoints
were observed in these groups (FRA1A, FRA1D, FRA1E
and FRA1J) [8]. The average incidence of chromosomal
breaks didn’t increase with the disease progression, but
the breakpoint distribution pattern was quite different.
Mild stage patients (group B) displayed higher frequen-
cies of breakpoints within the most common FSs,
FRA3B and FRA16D except for the patient with unbal-
anced karyotype (Table 2).
FA pathway plays an essential role in regulation of
maintenance and stability of CFSs [14]. Howlett et al.
[15], was the first who establishes that disrupted FA
pathway leads to increased chromosomal instability at
CFSs underlying that their stability depends on the
ATR-FANCD2 signaling pathway, i.e. following DNA
replication stress, ATR kinase phosphorylates FANCD2
promoting its monoubiqutination, which activates hom-
ologous recombination (HR). Replication stress leads to
accumulation of FANCD2 protein in the chromosomal
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Fig. 4 Chromosomes involved in telomere fusions in group A and B
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Fig. 5 Chromosomes involved in radial figures in both patient groups
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regions prone to breakage, whether they are broken or
not [16]; however altered FANCD2 protein in FA-D2
cells couldn’t maintain stability of existing FSs which in
turn activates alternative mechanisms of repair. Apart
from HR the CFSs are maintained by non-homologous
end-joining (NHEJ) mechanisms, as well as with special-
ized polymerases that perform by-pass function in DNA
synthesis [17, 18].
On the other hand, CFSs are AT-rich sequences prone
to form DNA secondary structures which can lead to
the replication fork collapse [19]. In addition, replication
timing is delayed along CFSs, whereas exposure to DNA
polymerase inhibitors intensifies the deceleration of the
fork progression, so the CFSs enter G2 phase unrepli-
cated [20]. Both give rise for chromosomal breaks.
Increasing body of evidence now show that large genes
constitute the pool of CFSs [21] indicating relationship
between instability and transcription of these genes.
Since more than one cell cycle is required for their tran-
scription, transcription and replication machineries col-
lide and CFSs expression may occur [22]. Although
different FS distribution pattern with the disease pro-
gression remains unclear, it is possible that with the pro-
gression of the disease different genes could be
expressed as a cellular attempt to compensate progres-
sive genomic instability, leading to different CFSs
expression.
Up to now, 19 CFSs have been molecularly character-
ized [23]. Among them are the most common FSs
(FRA3B and FRA16D, Table 3) which both contain very
large genes (>1 Mbp) important for tumor suppression.
These FSs are, along with FRA7H, most frequently
expressed in mild stage. In severe stage of the disease
different FSs appear as the most common. These
chromosomal regions are also very large, extending from
2 to 6 Mbp, but are comprised by a great number of
genes (Table 3); many of those are included in control of
cell cycle and tumor suppression. For example, BCL2
gene (spans approximately 200 kbp), which is the first
discovered anti-apoptotic gene, is located within
FRA18B, whereas it is known that breakpoints and
translocations within this region disrupt its function and
lead to myeloproliferative diseases [24]. Similarly, proto-
oncogene C-FOS, located within FRA14G, also has im-
portant role in regulation of cell proliferation and
differentiation [25].
Patients in the severe stage of the disease have sig-
nificantly higher percentage of telomere fusions com-
pared to the patients in the mild stage. Interestingly,
there was no significant difference in average telo-
mere length between two groups of patients, but
measurement of telomere length at each individual
chromosome revealed that the chromosomes with the
shortest telomeres were most frequently involved in
telomere fusions. Our previous research showed that
lymphocyte telomeres in FA-D2 patients are short-
ened when compared to the age-matched control
[10]. Taking into account that FA cells are breakage
prone, increased breakages at telomeres and complexity of
their function could be the cause of their shortening. Re-
cent review of Holohan et al. [26] pointed out that im-
paired telomere maintenance and attrition is a hallmark of
FA-D2 group, not FA in general. Our previous study
showed that FA-D2 cells displayed heterogeneous telo-
mere length and high frequency of double-strand breaks
in telomere regions (telomere dysfunction–induced foci -
TIFs) which lead to telomere fragility [10]. Altered
FANCD2 protein is not capable to maintain telomeres,
Fig. 6 Representative images of telomere FISH in FA-D2 metaphases. Telomere signals at the fusion points are indicated by green arrow: telomere
end-to-end fusion, three signals are present between two chromosomes (a), radial figure between chromosomes X and 13, red arrow indicates X
chromosome in radial figure (b), green arrow indicates radial figure between telomere of one and interstitial region of another chromosome (c),
blue arrow indicates simple radial figure (d). Scale bars = 10 μm
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leaving the telomeres unprotected and prone to increased
fragility and attrition.
FA-D2 patients in the severe stage had significantly
more radials than the patients in the mild phase of the
disease, particularly radials formed between telomeres of
one and interstitial chromosomal regions of other chro-
mosomes, which was rarely observed in group B. This is
unreported finding. Since shortened and fragile telo-
meres act as double strand breaks (DSB) interchromo-
somal recombination with other impaired chromosomal
regions in attempt to repair the damage is not surpris-
ing. Additionally, two patients in severe stage developed
bone marrow failure several months after cytogenetic
examination and became candidates for bone marrow
transplantation.
In both groups of patients, radials were composed of
non-homologous chromosomes, which is consistent with
the previously reported results [27, 28]. Distribution of
involved chromosomes was heterogeneous and not spe-
cific for the disease stage. However, X chromosome was
found in radials in both groups of patients, which is op-
posite to the report of Newell and colleagues [27], who
found that sex chromosomes are not involved in FA-A
and FA-G cells and suggested that alternative mecha-
nisms of ICL repair, which avoid recombination between
sex and autosome chromosomes, play the main repair
role in FA cells. Involvement of Y chromosome was not
observed, but only one male patient in the mild stage
and with very low number of radials was part of the
study. The presence of sex chromosomes in radial fig-
ures in FA patients was not previously reported.
Although radials are described in many genomic in-
stability syndromes, only a few studies clarified the mech-
anism of their formation. Kuhn and Therman [29] and
Scully et al. [30], suggested that they arise as an attempt of
cellular repair machinery to resolve DSBs, especially when
cells with hampered repair machinery are exposed to ICL-
s employing homologous recombination [31, 32]. Radials
formation in FA cells between non-homologous chromo-
somes, as well as between autosomes and sex chromo-
somes indicate that short dispersed chromosomal regions
that share homology could act as repair templates in re-
solving the DNA damage. In FA-D2 cells the X chromo-
some is not spared from such recombination.
Conclusions
Overall, our results indicate that regions with increased fre-
quency of breakage co-localize with CFSs, whereas their
distribution pattern relates to the severity of the disease.
Telomere fusions, as well as interchromosomal recom-
bination and radials formation which involve telomere
sequences are the consequence of critically shortened
telomeres, increase with disease progression and could
be of predictive value.
Table 3 Genes located within common fragile sites according to the literature dataa, b, c, d
Fragile site Chromosomal region Start End Gene Gene length
Molecularly characterized fragile sites
FRA3B 3p14.2 58 600 001 63 800 000 FHITa >1.5 Mbp
FRA7H 7q32.3 130 800 001 132 900 000 /b /
FRA16D 16q23.2 79 200 001 81 600 000 WWOXc 1.1 Mbp
Not-characterized fragile sitesd
FRA1F 1q21.2 147 500 001 150 600 000 33 genes /
FRA1N 1p13.3 106 700 001 111 200 000 52 genes /
FRA2U 2q35 214 500 001 220 700 000 70 genes /
FRA3C 3q27.1 183 000 001 184 800 000 20 genes /
FRA3H 3p21.31 44 200 001 50 600 000 78 genes /
FRA5K 5q13.2 69 100 001 74 000 000 25 genes /
FRA5O 5q33.2 153 300 001 156 300 000 8 genes /
FRA7F 7q22.3 104 900 001 107 800 000 14 genes /
FRA11H 11q13.4 70 500 001 75 500 000 48 genes /
FRA14G 14q24.3 73 300 001 78 800 000 69 genes /
FRA16C 16q22.1 66 600 001 70 800 000 95 genes /
FRA18B 18q21.3 61 300 001 63 900 000 10 genes /
aAccording to Zimonjic et al. [37]
bAccording to Mishmar et al. [38]
cAccording to Ried et al. [39]
dAccording to National Center for Biotechnology Information [40]
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